EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update - Smolen, J. S.; Landewe, R. B. M.; Bergstra, S. A.; Kerschbaumer, A.; Sepriano, A.; Aletaha, D.; Caporali, R.; Edwards, C. J.; Hyrich, K. L.; Pope, J. E.; de Souza, S.; Stamm, T. A.; et al. (Ann Rheum Dis, 2023)